Mary Jayne Crocker - 13 Nov 2025 Form 4 Insider Report for Bridgewater Bancshares Inc (BWB)

Signature
/s/ Ben Klocke, Attorney-in-Fact
Issuer symbol
BWB
Transactions as of
13 Nov 2025
Net transactions value
+$71,644
Form type
4
Filing time
17 Nov 2025, 17:34:10 UTC
Previous filing
12 Nov 2025
Next filing
24 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Crocker Mary Jayne EVP & CHIEF STRATEGY OFFICER C/O BRIDGEWATER BANCSHARES, INC., 4450 EXCELSIOR BLVD., SUITE 100, ST. LOUIS PARK /s/ Ben Klocke, Attorney-in-Fact 17 Nov 2025 0001732716

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BWB Common Stock Sale $69,524 -4,080 -2% $17.04 199,025 13 Nov 2025 Direct F1
transaction BWB Common Stock Options Exercise $141,168 +18,898 +9.5% $7.47 217,923 17 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BWB Option to buy Options Exercise $0 -18,898 -17% $0.000000 91,102 17 Nov 2025 Common Stock 18,898 $7.47 Direct F2, F3
holding BWB Option to buy 27,000 13 Nov 2025 Common Stock 27,000 $12.92 Direct F2, F4
holding BWB Option to buy 20,000 13 Nov 2025 Common Stock 20,000 $17.50 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.10, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
F2 Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan.
F3 Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017.
F4 Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019.
F5 Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022.